USHOPAL Funding, Investors & Competitors

USHOPAL has raised $102M across 2 funding rounds, most recently a $100M Series D in March 2021.

Last USHOPAL funding round

$100M

Series D · Mar 2021

Cumulative funding USHOPAL raised

$102M

across 2 funding rounds

Key investors in USHOPAL

  • SOSV
  • Orbit Startups
  • Cathay Capital
  • Hengxu Capital
  • Chinaccelerator
  • Eminence Ventures
  • FountainVest Partners
  • Light-Up Capital

USHOPAL Overview

About USHOPAL

USHOPAL is a brand acceleration group headquartered in Shanghai, China. It helps global luxury and wellness brands expand through omnichannel strategies, data analytics, and investments in beauty innovators. Services include market entry, e-commerce on Tmall and Douyin, offline retail, and supply chain management. USHOPAL partners with international labels to scale in the Chinese market, focusing on skincare, fragrances, and personal care products.


Founded

2017

HQ

ChinaShanghai

Status

Privately held

Customer focus

B2B

Revenue model

Services

USHOPAL Funding History

USHOPAL has raised a total of $102M across 2 funding rounds.

USHOPAL's first fundraising round was a $2M Series A in January 2017. The most recent completed round was a $100M Series D in March 2021.

USHOPAL funding rounds

USHOPAL funding rounds
DateStageInvestorsRaisedDeal Summary
Mar 2021Series DFountainVest Partners (lead); Eminence Ventures; Hengxu Capital; Dazhong Zhongsong Fund; Chinaccelerator; Orbit Startups; Zhongyuan Capital; SOSV; Cathay Capital$100MUSHOPAL, founded in 2017, is a leading new luxury beauty and new retail group in China, positioned to introduce niche global luxury beauty brands with limited awareness in the Chinese market. These brands are typically sold at high-end retailers like Harrods, Le Bon Marché, and Neiman Marcus. USHOPAL provides omni-branding and growth services, including a fleet of over 2,500 luxury influencers, an in-house content studio, branding team, omni-channel growth team, Tmall retail operations, global logistics, and Bonnie & Clyde multi-brand stores and experience centers. On March 8, 2021, USHOPAL completed a Series D funding round raising $100 million USD, led by FountainVest Partners, with co-investors including Cathay Capital, Zhongyuan Capital, Hengxu Capital, and Dazhong Zhongsong Fund. This brought the total investment pool to $200 million USD. The funds are aimed at supporting portfolio brands' rapid growth in China and Asia Pacific, investing in Bonnie & Clyde experience centers, and expanding the brand matrix. Some sources describe USHOPAL (also referred to as Shopal) variably as a software solutions provider for offline retailers in cosmetics, offering a mobile app for staff-customer communication, backend for customer segmentation, sales prediction, data analytics, and product location features to help global beauty brands scale in China. Founder and CEO Lu Guo emphasized leveraging the team's brand-building and omnichannel experience to turn niche brands into category leaders. USHOPAL has made investments, including in BULK HOMME in November 2021.
Jan 2017Series ALight-Up Capital; Integral Capital$2M-

Who has invested in USHOPAL?

11 investors have backed USHOPAL across its funding rounds, including SOSV, Orbit Startups, Cathay Capital, Hengxu Capital, Chinaccelerator and Eminence Ventures.

Lead investors include FountainVest Partners.


USHOPAL Investors

Investors in USHOPAL by funding rounds participated
InvestorHQRoundsRoleFirst check
Eminence VenturesChinaShanghai1ParticipantMar 2021
Hengxu CapitalChinaShanghai1ParticipantMar 2021
Dazhong Zhongsong FundChinaChina1ParticipantMar 2021
Light-Up CapitalChinaTianjin1ParticipantJan 2017
FountainVest PartnersHong KongHong Kong1LeadMar 2021
Integral CapitalUnited StatesPittsburgh, PA1ParticipantJan 2017
ChinacceleratorChinaChina1ParticipantMar 2021
Orbit StartupsSingaporeSingapore1ParticipantMar 2021
Zhongyuan CapitalChinaShanghai1ParticipantMar 2021

This data is available for Pro users. Sign up to see all 11 USHOPAL investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by USHOPAL

USHOPAL has acquired 1 company to date.

Last acquisition by USHOPAL was on October 12th 2022. USHOPAL acquired Argentum Apothecary for undisclosed valuation.


Latest Acquisitions by USHOPAL

Argentum Apothecary
Description
Argentum Apothecary is a London-based luxury skincare brand utilizing medical-grade silver in its formulations for anti-aging and repair. Launched in 2010, the line features la lotion infinie serum and apotheline restorative cream, blending colloidal silver with peptides and hyaluronic acid. Sold in 40 countries through Harrods and Neiman Marcus, Argentum holds awards from Harper's Bazaar and Allure for its 93 percent natural compositions clinically proven to reduce wrinkles by 28 percent in four weeks.
HQ CountryUnited Kingdom
HQ City
London
Deal Date12 Oct 2022
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all USHOPAL acquisitions and their M&A valuation multiples.

Start Free Trial

USHOPAL Competitors

USHOPAL competitors include listed companies like Vector, Accenture, HCLTech and Experian, and private ones like Authentic Brands Group and Ryan.

Public and private companies comparable to USHOPAL
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
VectorJapanJapanPublicly listed$403M$66M$606M1.3x
AccentureUnited StatesUnited StatesPublicly listed$74B$13B$154B2.1x
HCLTechIndiaIndiaPublicly listed$14B$2.7B$41B2.7x
ExperianIrelandIrelandPublicly listed$8.4B$3B$36B4.7x
Authentic Brands GroupUnited StatesNew York City, NYPrivate--$20B-
RyanUnited StatesPlano, TXPrivate--$7B-

USHOPAL Public Comps

USHOPAL is still privately-owned, but its public comps include Accenture, HCLTech, Experian, Cognizant, Publicis Groupe, Verisk Analytics, Omnicom Group, Capgemini, Equifax and Nomura Research Institute.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Accenture$74B$13B2.1x2.1x12.4x11.0x
HCLTech$14B$2.7B2.8x2.7x14.4x12.9x
Experian$8.4B$3B4.9x4.7x13.7x13.0x
Cognizant$21B$4B1.4x1.3x7.5x7.2x
Publicis Groupe$20B$3.5B1.7x1.9x9.3x8.7x
Verisk Analytics$3.1B$1.7B9.9x9.5x18.2x16.8x
Omnicom Group$17B$721M1.8x1.3x44.2x7.9x
Capgemini$25B$3.3B1.3x1.2x9.8x7.8x

This data is available for Pro users. Sign up to see all USHOPAL competitors and their valuation data.

Start Free Trial

Common questions about USHOPAL

When was USHOPAL founded?USHOPAL was founded in 2017.
Where is USHOPAL headquartered?USHOPAL is headquartered in Shanghai, China.
Is USHOPAL publicly listed?No, USHOPAL is a private, VC-backed company.
How much funding has USHOPAL raised?USHOPAL has raised $102M across 2 funding rounds.
What was USHOPAL's last funding round?USHOPAL's last funding round was a $100M Series D in March 2021, led by FountainVest Partners.
Who are USHOPAL's investors?USHOPAL's investors include Eminence Ventures, Hengxu Capital, Dazhong Zhongsong Fund, Light-Up Capital, FountainVest Partners, Integral Capital, Chinaccelerator, Orbit Startups, Zhongyuan Capital, SOSV and 1 other.
Which companies are comparable to USHOPAL?Companies comparable to USHOPAL include Vector, Accenture, HCLTech, Experian, Authentic Brands Group and Ryan.
How many companies has USHOPAL acquired?USHOPAL has acquired 1 company, including Argentum Apothecary.

See companies similar to USHOPAL

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial